GSK Sees Light At End Of Shingrix Tunnel As COVID-19 Eases

Company Records Steep Sales Decline For Shingles Vaccine in Q1

 
• By Alaric DeArment
  
Shingles_1200
GSK forecasts stronger sales for its shingles vaccine, Shingrix, in the latter half of 2021 and 2022 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business